1. Moderna Appoints Israel Ruiz to Its Board of Directors

    Moderna Appoints Israel Ruiz to Its Board of Directors

    Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA Therapeutics™ to create a new generation of transformative medicines for patients, announced today the appointment of Israel Ruiz, Executive Vice President and Treasurer of the Massachusetts Institute of Technology, to the company's Board of Directors, where he will serve as Audit Committee Chair...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

    1. We are delighted to welcome Israel to Moderna's Board of Directors. His progressive leadership at MIT has helped ensure the continued, unparalleled contributions of the Institute on a regional, national and global scale, through education, innovation and entrepreneurship.
    2. A critical component of Moderna's success to date has been our ability to tap into a breadth of viewpoints and guidance from leading experts across the corporate and academic worlds. To that end, we are thrilled that Israel is joining the Moderna board.
  3. Topics Mentioned